Donna Seger

1.8k total citations
49 papers, 1.1k citations indexed

About

Donna Seger is a scholar working on Emergency Medicine, Toxicology and Pharmacology. According to data from OpenAlex, Donna Seger has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Emergency Medicine, 8 papers in Toxicology and 7 papers in Pharmacology. Recurrent topics in Donna Seger's work include Poisoning and overdose treatments (21 papers), Forensic Toxicology and Drug Analysis (7 papers) and Venomous Animal Envenomation and Studies (6 papers). Donna Seger is often cited by papers focused on Poisoning and overdose treatments (21 papers), Forensic Toxicology and Drug Analysis (7 papers) and Venomous Animal Envenomation and Studies (6 papers). Donna Seger collaborates with scholars based in United States, France and Australia. Donna Seger's co-authors include Peter A. Chyka, Lindsay Murray, Andrew Walubo, Larry W. Welch, Keith D. Wrenn, Seth W. Wright, Jerrold L. Abraham, Lloyd E. King, Alan S. Boyd and Candace D. McNaughton and has published in prestigious journals such as Circulation, Journal of the American Academy of Dermatology and MMWR Morbidity and Mortality Weekly Report.

In The Last Decade

Donna Seger

47 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Seger United States 18 449 153 141 140 139 49 1.1k
S. Rutherfoord Rose United States 17 478 1.1× 138 0.9× 120 0.9× 159 1.1× 158 1.1× 53 1.2k
Suzanne White United States 13 580 1.3× 92 0.6× 143 1.0× 102 0.7× 86 0.6× 27 1.2k
F. Lee Cantrell United States 20 393 0.9× 165 1.1× 75 0.5× 128 0.9× 107 0.8× 80 1.0k
Jay L. Schauben United States 11 462 1.0× 100 0.7× 107 0.8× 85 0.6× 101 0.7× 24 962
Anthony F. Pizon United States 21 318 0.7× 129 0.8× 91 0.6× 153 1.1× 134 1.0× 82 1.1k
Keith Burkhart United States 22 496 1.1× 129 0.8× 106 0.8× 187 1.3× 110 0.8× 66 1.4k
Elizabeth J. Scharman United States 22 640 1.4× 182 1.2× 133 0.9× 82 0.6× 102 0.7× 33 1.3k
Douglas J. Borys United States 15 484 1.1× 170 1.1× 99 0.7× 95 0.7× 77 0.6× 29 1.1k
Blaine E. Benson United States 16 883 2.0× 220 1.4× 177 1.3× 92 0.7× 103 0.7× 33 1.6k
Marsha Ford United States 15 1.0k 2.3× 183 1.2× 166 1.2× 124 0.9× 162 1.2× 26 1.7k

Countries citing papers authored by Donna Seger

Since Specialization
Citations

This map shows the geographic impact of Donna Seger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Seger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Seger more than expected).

Fields of papers citing papers by Donna Seger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Seger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Seger. The network helps show where Donna Seger may publish in the future.

Co-authorship network of co-authors of Donna Seger

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Seger. A scholar is included among the top collaborators of Donna Seger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Seger. Donna Seger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mullins, Michael E. & Donna Seger. (2025). Urgent need for reversal agents for xylazine and other imidazolines in illicit fentanyl. The American Journal of Emergency Medicine. 97. 129–130.
2.
Bruccoleri, Rebecca, et al.. (2024). Comparing the Use of Crotaline-Polyvalent Immune Fab (Ovine) Versus Observation in Children. Pediatric Emergency Care. 40(11). e270–e276.
3.
Seifert, Steven A., Nicholas A. Buckley, Betty S. Chan, et al.. (2022). Clinical Toxicology Review Metrics and Expert Reviewers, 2021. Clinical Toxicology. 60(4). e1–e3. 1 indexed citations
4.
Fill, Mary‐Margaret A., Donna Seger, John R. Dunn, William Schaffner, & Timothy F. Jones. (2016). Notes from the Field: Intoxication and Deaths Associated with Ingestion of a Racing Fuel and Carbonated Soft Drink Mixture — Tennessee, January 2016. MMWR Morbidity and Mortality Weekly Report. 65(22). 585–586. 1 indexed citations
5.
Kryshtal, Dmytro O., Sheila Dawling, Donna Seger, & Björn C. Knollmann. (2015). In Vitro Studies Indicate Intravenous Lipid Emulsion Acts as Lipid Sink in Verapamil Poisoning. Journal of Medical Toxicology. 12(2). 165–171. 16 indexed citations
6.
Seger, Donna, Kimberly A. Barker, & Candace D. McNaughton. (2013). Misuse of the Naranjo Adverse Drug Reaction probability scale in toxicology. Clinical Toxicology. 51(6). 461–466. 38 indexed citations
7.
Seger, Donna, et al.. (2010). Systemic Loxoscelism in the Age of Community-Acquired Methicillin-Resistant Staphylococcus aureus. Annals of Emergency Medicine. 57(2). 138–140. 6 indexed citations
8.
Kryshtal, Dmytro O., Sheila Dawling, Donna Seger, & Björn C. Knollmann. (2010). Abstract 18810: Intralipid as Novel Antidote for Verapamil Poisoning. Circulation. 122. 1 indexed citations
9.
Seger, Donna, et al.. (2009). Systemic loxoscelism. Clinical Toxicology. 47(5). 430–431. 1 indexed citations
11.
Seger, Donna, Stephen E. Kahn, & Edward P. Krenzelok. (2005). Treatment of US Crotalidae Bites. PubMed. 24(4). 217–227. 9 indexed citations
12.
Seger, Donna. (2004). Flumazenil—Treatment or Toxin. Journal of Toxicology Clinical Toxicology. 42(2). 209–216. 47 indexed citations
13.
Fakhoury, Toufic, Lindsay Murray, Donna Seger, Michael McLean, & Bassel Abou‐Khalil. (2002). Topiramate Overdose: Clinical and Laboratory Features. Epilepsy & Behavior. 3(2). 185–189. 27 indexed citations
14.
Seger, Donna. (2002). Clonidine Toxicity Revisited. Journal of Toxicology Clinical Toxicology. 40(2). 145–155. 41 indexed citations
15.
Murray, Lindsay & Donna Seger. (1994). Hemolytic Anemia Following a Presumptive Brown Recluse Spider Bite. Journal of Toxicology Clinical Toxicology. 32(4). 451–456. 20 indexed citations
16.
Seger, Donna & Larry W. Welch. (1994). Carbon Monoxide Controversies: Neuropsychologic Testing, Mechanism of Toxicity, and Hyperbaric Oxygen. Annals of Emergency Medicine. 24(2). 242–248. 58 indexed citations
17.
Longmire, Atkinson W. & Donna Seger. (1993). Topics in Clinical Pharmacology: Flumazenil, a Benzodiazepine Antagonist. The American Journal of the Medical Sciences. 306(1). 49–52. 10 indexed citations
18.
Barsan, William G., Anthony J. Tomassoni, Donna Seger, et al.. (1993). Safety assessment of high-dose narcotic analgesia for emergency department procedures. Annals of Emergency Medicine. 22(9). 1444–1449. 19 indexed citations
19.
Barsan, William G., Donna Seger, Daniel F. Danzl, et al.. (1989). Duration of antagonistic effects of nalmefene and naloxone in opiate-induced sedation for emergency department procedures. The American Journal of Emergency Medicine. 7(2). 155–161. 33 indexed citations
20.
Seger, Donna. (1988). Toxic emergencies of endocrine and metabolic therapeutic agents. Journal of Emergency Medicine. 6(6). 527–537. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026